FDA 483 - Fresenius Kabi USA, LLC - March 18, 2022

An FDA inspection of Ivenix, Inc. in North Andover, MA, identified a significant issue related to design verification. The firm failed to confirm that design output meets design input requirements, specifically regarding the pressure resistance of administration set drip chambers. This indicates a moderate severity finding concerning product design and testing.